VR Logo

Unrated

IDBI Healthcare Fund - Regular Plan


Equity: Sectoral-Pharma

1 Lakh

Investment Grown to
₹ 1.58 Lakh

₹ 10000

Monthly SIP Grown to
₹ 1.67 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund 45.75 4.53 6.77 17.85 22.33 37.70 57.74 -- -- -- --
S&P BSE Healthcare TRI 47.13 4.70 6.82 18.74 28.88 38.74 55.76 -- -- -- --
Equity: Sectoral-Pharma 48.51 4.45 6.57 18.63 26.07 38.35 59.54 -- -- -- --
Rank within category 7 6 5 7 9 6 7 -- -- -- --
Number of funds in category 9 9 9 9 9 9 9 4 3 3 3

As on 10-Aug-2020

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
IDBI Healthcare Fund - Regular Plan
Unrated
Feb-19 57.74 -- -- 2.56 41
Nippon India Pharma Fund
Unrated
Jun-04 60.30 23.04 9.28 2.07 3,496
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund  | Invest Now
Unrated
Jul-18 61.76 -- -- 2.33 1,749
SBI Healthcare Opportunities Fund  | Invest Online
Unrated
Jul-99 61.26 14.62 4.02 2.43 1,284
Mirae Asset Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jul-18 67.90 -- -- 2.43 773

Best & Worst Performance

Best (Period) Worst (Period)
Week 21.25 (01-Apr-2020 - 09-Apr-2020) -10.89 (05-Mar-2020 - 12-Mar-2020)
Month 34.24 (23-Mar-2020 - 22-Apr-2020) -19.39 (20-Feb-2020 - 23-Mar-2020)
Quarter 43.01 (23-Mar-2020 - 22-Jun-2020) -12.18 (23-Dec-2019 - 23-Mar-2020)
Year 52.97 (05-Aug-2019 - 04-Aug-2020) -7.88 (22-Mar-2019 - 23-Mar-2020)

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund -- -- -- -- -- --
S&P BSE Healthcare TRI* 11.82 23.98 0.28 0.67 -- --
Equity: Sectoral-Pharma* 13.88 21.14 0.41 0.86 0.86 3.01
Rank within category -- -- -- -- -- --
Number of funds in category -- -- -- -- -- --

The Risk Measures have been calculated using calendar month returns for the last three years.

As on

* As on 31-Jul-2020

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 28
Top 10 Stocks (%) 61.85
Top 5 Stocks (%) 43.53
Top 3 Sectors (%) 95.12
Portfolio P/B Ratio 4.89
Portfolio P/E Ratio 39.40

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 39,883 32,553
Giant (%) 13.20 11.11
Large (%) 46.39 46.61
Mid (%) 37.38 29.13
Small (%) 3.02 13.14
Tiny (%) -- --

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
equal Dr. Reddy's Lab Healthcare 39.29 11.67 0.00 11.03
down Sun Pharmaceutical Inds. Healthcare 179.84 12.79 0.00 11.03
equal Divi's Laboratories Healthcare 52.15 10.41 0.00 8.95
equal Cipla Healthcare 38.14 7.64 0.00 7.03
equal Ipca Laboratories Healthcare 41.85 6.88 0.00 5.49
equal Aurobindo Pharma Healthcare 19.55 5.97 0.00 4.70
down Lupin Healthcare -- 6.19 0.00 3.90
equal Alembic Pharmaceuticals Healthcare 21.72 3.80 0.00 3.61
equal Torrent Pharmaceuticals Healthcare 42.98 3.69 0.00 3.25
equal Natco Pharma Healthcare 34.21 4.08 0.00 2.86
equal Apollo Hospitals Healthcare 53.55 4.15 0.00 2.86
equal Abbott India Healthcare 53.88 4.21 0.00 2.77
equal Dr. Lal Pathlabs Healthcare 79.40 4.13 0.00 2.73
equal Alkem Laboratories Healthcare 24.42 4.43 0.00 2.60
equal Cadila Healthcare Healthcare 30.47 2.30 0.00 2.18
equal Pfizer Healthcare 40.50 4.05 0.00 2.11
equal Laurus Labs Healthcare 27.36 1.99 0.00 1.99
equal Sanofi India Healthcare 43.95 5.59 0.00 1.94
equal Syngene International Healthcare 49.52 2.80 0.00 1.83
equal Aarti Industries Chemicals 33.37 2.30 0.00 1.69
equal JB Chemicals & Pharma Healthcare 21.83 1.77 0.00 1.61
equal ICICI Lombard General Insurance Company Financial 47.79 2.16 0.00 1.55
equal Biocon Healthcare 70.68 2.37 0.00 1.54
equal HDFC Life Insurance Financial 92.93 1.53 0.00 1.53
new Aster DM Healthcare Healthcare 24.53 1.26 0.00 1.26

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-Jul-2020

Fund Manager

— Uma Venkatraman since 08-Feb-2019

Education: Prior to joining IDBI Mutual Fund, she had worked with B&K Securities, ASK Raymond James, Morgan Keegan and UTI Mutual Fund.

Funds Managed:


4.53%

Change from previous, NAV as on 10-Aug-2020

Growth: ₹ 15.4500

Dividend: ₹ 15.4500


Investment Strategy

The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.

Investment Details

Minimum Investment (₹) 5,000
Minimum Addl Investment (₹) 1,000
Minimum SIP Investment (₹) 500
Minimum No of Cheques 12
Minimum Withdrawal (₹) 1,000
Minimum Balance (₹) 1
Exit Load 1% for redemption within 365 days

Basic Details

Fund House: IDBI Mutual Fund
Launch Date: 28-Feb-2019
Return Since Launch: 35.01%
Benchmark: S&P BSE Healthcare TRI
Riskometer: High
Type: Open-ended
Assets: ₹ 41 Cr (As on 31-Jul-2020)
Expense: 2.56% (As on 30-Jun-2020)
Risk Grade: --
Return Grade: --
Turnover: 65.00%

Contact Information

AMC: IDBI Asset Management Ltd.

Address: 4th Floor, IDBI Tower, WTC Complex, Cuffe Parade, Colaba, Mumbai - 400005

Phone: 022-66442800 / 1800-419-4324

Fax: 022-66442801

Email: [email protected]

Website: http://www.idbimutual.co.in

Registrar & Transfer Agent: KFin Technologies Pvt Ltd.

Address: 303, Vamsee Estates, Opp. Big Bazaar, Ameerpet, Hyderabad - 500016

Phone: 040-44857874

Email: [email protected]

Website: www.karvymfs.com

Upcoming Video

Investors' Hangout

Attaining financial independence

dateFriday, 14-Aug-2020
time12:30 PM - 01:00 PM